SafeHeal Appoints Medical Device Industry Veteran Chris Richardson as Chief Executive Officer
PARIS, FRANCE and TAMPA, FL / ACCESSWIRE / July 11, 2022 / SafeHeal, a leading innovator in the field of...
Month: July 2022
Moderna’s Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized Booster
mRNA-1273.214 has now demonstrated significantly higher antibody titers against all tested variants, including Omicron BA.1 and BA.4/5 subvariants, ancestral virus,...
Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation
SANTA BARBARA, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a leading medical...
CytoDyn Highlights NIH Grant for HIV Functional Cure Preclinical Study of Gene Therapy Based on Leronlimab
$5 Million Grant Awarded to OHSU for Preclinical Research of One-time Injection of Gene Therapy Based on Leronlimab for Functional...
Femasys to Participate in the Women’s Health Panel Discussion Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, July 13th at 11 a.m. ET
ATLANTA, July 11, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide...
Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.
RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special...
Missouri Health System Signs New Contract for Streamline Health® eValuator™
Not-for-Profit Organization Chooses Automated Pre-Bill Coding Analysis to Improve Financial Performance Atlanta, GA, July 11, 2022 (GLOBE NEWSWIRE) -- Streamline...
Reneo Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
IRVINE, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on...
Dependable Health Services Attracts Investment from M33 Growth & Adds Seasoned Executive John Sanders as CEO
The investment and added leadership will accelerate growth and expand relationships for the medical and non-medical staffing business.SAN ANTONIO, July...
Arcutis Biotherapeutics Announces Health Canada Accepts for Review the New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis
Submission supported by positive clinical data from the pivotal Phase 3 DERMIS-1 and DERMIS-2 clinical studies, as well as results...
Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film
Study results for the sublingual administration of AQST-109 epinephrine oral film after consuming a peanut butter sandwich demonstrates consistent Tmax...
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel
Molecular Diagnostic Test for Early Detection of Lyme DiseaseLEXINGTON, Mass., July 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO)...
Oregon State Athletics, P3 Health Partners Oregon Announce Multi-Year Relationship
New Beavers’ Affiliation Leverages P3’s Commitment to the Senior Community, Presence Among FansCORVALLIS, Ore., July 11, 2022 (GLOBE NEWSWIRE) --...
Kala Pharmaceuticals Completes Sale of EYSUVIS® and INVELTYS® to Alcon Inc
ARLINGTON, Mass, July 11, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research,...
DLH Awarded NIH Cancer Epidemiology and Genetics Contract
ATLANTA, July 11, 2022 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
Apexigen to Participate in the Brookline Capital Markets Newport Symposium
SAN CARLOS, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative antibody-based...
Cue Biopharma to Present at the Guggenheim I&I Spotlight Series
BOSTON, July 11, 2022 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class...
Athenex Announces Entry into Agreement to Sell its China API Business to TiHe Capital (Bejing) Co., Ltd.
Expected sale proceeds of approximately $19.0 millionCompany continues to monetize non-core assets to extend cash runwayProceeds from the deal will...
SAB Biotherapeutics Announces Election of Rear Admiral (retired) Scott Giberson, RPh, MPH, D.Sc., to Board of Directors
SIOUX FALLS, S.D., July 11, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a...
Healthcare Triangle Announces $6.5 Million Private Placement
PLEASANTON, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the “Company”), a leading provider...